ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1203

Psychometric Properities of the Patient Related Outcome Measure FACIT-Fatigue in Rheumatic Arthritis and Psoriatic Arthritis: A Literature Review

M. Elaine Husni1, Mark Kosinski 2, Regina Rendas-Baum 2, Shelly Kafka 3, Chenglong Han 4, Eric K H Chan 4, Elizabeth Hsia 5 and Arthur Kavanaugh 6, 1Department of Rheumatologic and Immunologic Diseases, Cleveland Clinic, Cleveland, OH, 2Optum, Johnston, RI, 3Janssen Scientific Affairs, LLC, Horsham, PA, 4Janssen Research & Development, LLC, Spring House, PA, 5Janssen Research & Development, LLC/University of Pennsylvania, Spring House/Philadelphia, PA, 6University of California, San Diego School of Medicine, La Jolla, CA

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: FACIT-Fatigue, Psoriatic arthritis, rheumatoid arthritis (RA) and patient-reported outcome measures

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 11, 2019

Title: Measures Of Healthcare Quality Poster II: Improving Care

Session Type: Poster Session (Monday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Fatigue is an important patient reported outcome in rheumatoid arthritis (RA) and psoriatic arthritis (PsA) research.  FACIT-Fatigue is a 13-item patient reported outcome (PRO) instrument designed to assess fatigue and its impact on daily activities and function over the past seven days. In this study we reviewed published evidence on the psychometric properties of FACIT-Fatigue in patients with rheumatoid arthritis (RA) or psoriatic arthritis (PsA) including content validity, reliability, , and ability to detect change.

Methods: For content validity, a search of PubMed and Ovid databases used the following terms: (“conceptual” OR ”content validity” OR “qualitative” OR “debrief*”) AND (“rheumatoid arthritis”/”psoriatic arthritis” OR “RA”/”PsA”) AND “fatigue”. For the psychometric measures, the search used the following terms: (“FACIT-F” OR “FACIT-Fatigue” OR “FACIT Fatigue”) AND (“rheumatoid arthritis”/”psoriatic arthritis” OR “RA”/PsA”) AND “fatigue.” Search filters were used to exclude: 1) articles that are not available in the English language; and 2) articles not published within the last 15 years (2001 – 2016).  Abstracts and full-publications involving observational cohorts and clinical trials were reviewed for reports of FACIT-Fatigue psychometric properties in RA and PsA patient studies.

Results: A total of 81 papers were included in this study. The content of the FACIT-Fatigue items maps well to descriptors used by patients to express their experience of RA-related fatigue, and almost all of the items (except the item “too tired to eat”) were found to be acceptable by patients, supporting its content validity. The instrument also possesses good to excellent reliability, including Cronbach’s alpha (≥ 0.80), test-retest reliability, and intra-class correlation. Moderate to high correlations were also found between the FACIT-Fatigue and other measures of fatigue, as well as measures of disability and disease activity, such as HAQ-DI, DAS28, Psoriasis Area and Severity Index and, Psoriasis Disability Index. The known-groups validity of the instrument was also demonstrated in studies of RA and PsA patients based on disease status and scores relative to the general population. Studies also showed that changes in FACIT-Fatigue scores were associated with changes in multiple clinical outcome measures, such as ACR improvement criteria, changes in DAS28, and physician global assessment, suggesting the ability of the FACIT-Fatigue to detect changes in RA and PsA disease activity. Table 1 summarizes the content validity evidence and Table 2 provides summaries of the psychometric properties of FACIT-Fatigue.

Conclusion: This review demonstrated evidence of content validity and strong psychometric properties of FACIT-fatigue in patients with RA and PsA, supporting its use in RA and PsA studies.


Disclosure: M. Husni, Abbvie, 5, AbbVie, Amgen, Eli Lilly, Janssen, Novartis, Pfizer, Regeneron, Sanofi-Genzyme, UCB, 5, Abbvie, Amgen, Janssen, Novartis, Lilly, Regeneron, Pfizer and UCB, 5, Bristol-Myers Squibb, 5, Eli Lilly, 5, Genentech, 5, Janssen, 5, Janssen Research & Development, LLC, 2, 3, Novartis, 5, PASE questionnaires, 7, Pfizer, 5, Sanofi-Genzyme, 5, UCB, 5; M. Kosinski, Janssen Research & Development, LLC, 2; R. Rendas-Baum, Janssen Research & Development, LLC, 2; S. Kafka, Janssen Research & Development, LLC, 3, Janssen Scientific Affairs, LLC, 1, 3; C. Han, Janssen Research & Development, LLC, 3, Janssen Research & Development, LLC,, 3; E. Chan, Janssen Research & Development, LLC, 3; E. Hsia, Janssen Research & Development, LLC, 3; A. Kavanaugh, Abbott, 2, Abbott, Amgen, AstraZeneca, BMS, Celgene Corporation, Centocor-Janssen, Pfizer, Roche, UCB, 2, Amgen, 2, Bristol-Myers Squibb, 2, Eli Lilly, 5, Eli Lilly and Company, 5, Gilead Sciences, Inc., 2, Janssen, 2, Janssen Research & Development, LLC, 2, Novartis, 2, 5, Pfizer, 2, Pfizer Inc, 2, Roche, 2, UCB Pharma, 2.

To cite this abstract in AMA style:

Husni M, Kosinski M, Rendas-Baum R, Kafka S, Han C, Chan E, Hsia E, Kavanaugh A. Psychometric Properities of the Patient Related Outcome Measure FACIT-Fatigue in Rheumatic Arthritis and Psoriatic Arthritis: A Literature Review [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/psychometric-properities-of-the-patient-related-outcome-measure-facit-fatigue-in-rheumatic-arthritis-and-psoriatic-arthritis-a-literature-review/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/psychometric-properities-of-the-patient-related-outcome-measure-facit-fatigue-in-rheumatic-arthritis-and-psoriatic-arthritis-a-literature-review/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology